Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2018
|
| オンライン･アクセス: | https://doi.org/10.1016/j.ymthe.2018.06.008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|